RELEVANT STUDIES

Journal
Study
CSNF Principal Investigators
Leukemia
Efficacy and Safety of Ofatumumab and Bendamustine Followed by Ofatumumab Maintenance in Patients with Relapsed Indolent Non-Hodgkin Lymphoma After Prior Rituximab
Mehdi Moezi, MD
The New England Journal of Medicine
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
Bijoy Telivala, MD; Daniel Kobrinski, DO